For the global community to be able to achieve ambitious targets relating to the prevention and treatment of HIV, viral hepatitis and sexually transmitted infections (STIs), multiple types of medicines must be widely accessible to all affected populations in all countries.
The purpose of this rep...ort is to provide forecasts of future demand for medicines used in the fields of HIV, viral hepatitis and STIs. This report jointly presents medicines forecasts across three disease areas in recognition of the benefits of addressing HIV, viral hepatitis and STIs in a coordinated manner.
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                La collaboration avec les autorités nationales de gestion des catastrophes
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                This is an update of a seven-year TB and Leprosy national strategic plan (TBL-NSP), which extends from 2013 to 2020. The update focuses on the plan covering from 2017-20 and is based on the 2017 external mid-term programme review key findings and recommendations; the global and national End TB strat...e-gies and targets; stakeholders consultation and recent revision of the national TB guidelines.
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Shielding is a term used to describe the protection of individuals at high risk of severe COVID-19 illness by separating them from the general population.
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                No education system is effective unless it promotes the health and well-being of its students, staff and community. These strong links have never been more visible and compelling than in the context of the COVID-19 pandemic. Towards making every school a health-promoting school: Let’s start with a... shared vision based on the standards and indicators presented in this publication.
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Prices people pay for medicines.
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                DHS Further Analysis Reports No. 101
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                The development of this draft Proposed programme budget 2022–2023 comes at a unique moment for WHO. The world is in the grip of the coronavirus disease (COVID-19) pandemic and faces health, social and economic consequences on an unprecedented scale. Although it is not known when the COVID-19 pande...mic will end, recent encouraging vaccine results, in addition to the examples of countries that have achieved good results through public health measures, hold out the prospect of better days ahead. The full impact of the pandemic cannot yet be determined. But whatever its implications, the Secretariat will rise to the challenge and is ready to adapt so that it is fully equipped to support Member States for any eventuality in the future – to make sure that the world will never again have to face this kind of crisis.
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Integrating the prevention and control of noncommunicable diseases in HIV/AIDS, tuberculosis, and sexual and reproductive health programmes: implementation guidance
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Promoting People's Health to Enhance Social-economic Development
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                ATLAS on substance use (2010)— Resources for the prevention and treatment of substance use disorder
Accessed: 14.03.2019
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Technical Report
AIDS Medicines and diagnostics service
September 2016
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Globally each year, millions of people suffer illness or lose their lives because the vaccines, medicines and diagnostic tests that they need are either unavailable or unaffordable – and this lack of access to medicine is acute in low- and middle-in-
come countries (LMICs). While the COVID-19 pan...demic laid this inequity bare, it also saw the pharmaceutical industry develop and bring new vaccines and treat- ments to market at unprecedented speed. As the world emerges from the worst
of this crisis, pharmaceutical companies are now at an important juncture, where lessons learned from the pandemic can prove pivotal in finding solutions to bridge long-standing gaps in access to medicine in LMICs.
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                The Global guidance framework for the responsible use of the life sciences: mitigating biorisks and governing dual-use research (the framework) aims to provide values and principles, tools and mechanisms to support Member States and key stakeholders to mitigate and prevent biorisks and govern dual-u...se research.
Digital publication you can download the English, French, Spanish and Russian version
The framework adopts the One health approach and focuses on the role that responsible life sciences research can play in preventing and mitigating risks caused by accidents, inadvertent or deliberate misuse with the intention to cause harm to humans, nonhuman animals, plants and agriculture, and the environment.
                                                                    more